Unlock instant, AI-driven research and patent intelligence for your innovation.

A new method for synthesizing olaparib crude drug

A synthesis method and intermediate technology are applied in the field of preparation of high-purity olaparib raw materials, and can solve the problems of reducing dimer content and low yield, etc.

Active Publication Date: 2022-03-11
南京亿华药业有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] In order to solve the problem of low yield in the existing process route and the ubiquitous introduction of dimer impurities, the present invention adopts a new synthesis route, which can effectively increase the yield, and remove di polymer impurities, thereby greatly reducing the content of dimers in the finished product

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A new method for synthesizing olaparib crude drug
  • A new method for synthesizing olaparib crude drug
  • A new method for synthesizing olaparib crude drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1: Synthesis of IM1

[0029]

[0030] Add 11.0 g of dimethyl phosphite, 6.5 g of sodium methoxide, and 100 mL of methanol into a 250 mL three-necked flask in sequence, cool down in an ice bath to 0-5 degrees Celsius, add 7.5 g of SM1 in batches, and control the internal temperature to not exceed 10 degrees Celsius. Add 12.5 g of methanesulfonic acid dropwise and continue to stir for 0.5 hour after adding the solution at room temperature. After the dropping, the methanol is distilled off under reduced pressure, 150 mL of water is added, and extracted twice with 100 mL of dichloromethane. The organic layers are combined and washed with Dry over anhydrous magnesium sulfate for 0.5 hour, filter, and distill the filtrate under reduced pressure to obtain 10.2 g of white solid, with a yield of 84%. Using the area normalization method to analyze, the purity was 99.03%.

Embodiment 2

[0031] Example 2: Synthesis of IM2

[0032]

[0033] Add 10 g of IM1, 6.2 g of SM2, and 200 mL of tetrahydrofuran into a 500 mL three-necked flask in sequence, cool to 0-5 degrees Celsius in an ice bath, stir to dissolve, add 4.6 g of triethylamine dropwise, control the internal temperature to not exceed 10 degrees Celsius, and After stirring at room temperature for 12 hours, a light yellow solid precipitated out, distilled off THF under reduced pressure, added 100 mL of water and stirred for 1 hour, filtered, and the filter cake was dried under vacuum at 60°C for 4 hours to obtain 10.4 g of a yellow-green solid with a yield of 95%. There are two large peaks in the HPLC spectrum, and the ratio of the peak areas is about 1:3. This is because the intermediate IM2 is a mixture of cis and trans isomers. The area normalization method was used to analyze, and the purity of the two peaks added was 99.83%. The cis-trans isomer mixture does not need to be separated, and directly en...

Embodiment 3

[0034] Embodiment 3: the synthesis of IM3

[0035]

[0036] Add 10 g of IM2, 100 mL of water, and 7 g of sodium hydroxide into a 250 mL three-necked flask in turn, heat to 90°C and stir for 1 hour, then cool down to 70°C, add 28.9 g of 80% hydrazine hydrate dropwise, and control the internal temperature not to exceed 75 degrees Celsius, continue to stir at 70 degrees Celsius for 12 hours after dropping, drop to room temperature, adjust the pH to 2-3 with 2M hydrochloric acid, precipitate a light yellow solid, filter, and vacuum dry the filter cake at 70 degrees Celsius for 5 hours to obtain 11.1 g of a yellow solid. 99%. Using the area normalization method to analyze, the purity was 96.10%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention introduces a new synthetic method of the antineoplastic drug Olaparib, which utilizes the different chemical properties that the dimer impurity cannot form a salt and the intermediate of the previous step of Olaparib can form a salt, and adopts the method of acid-base inversion, The dimer impurities are effectively removed, and the HPLC purity of the finished product can reach 99.9%. This route effectively improves the yield of the finished product of olaparib, and the total yield of 6 steps reaches 42.4%, which is of great significance for the industrial production of olaparib.

Description

technical field [0001] The invention relates to a preparation method of a high-purity olaparib bulk drug. Background technique [0002] Olaparib (AZD2281), a polyadenosine diphosphate-ribose polymerase (PARP) inhibitor, was developed by KuDOS Pharmaceuticals, a wholly-owned subsidiary of AstraZeneca, and the drug was approved by the FDA in December 2014 Approved for marketing, for the treatment of ovarian cancer and breast cancer with BRCA gene deficiency. The chemical name of Olaparib is 1-(cyclopropylformyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzyl Acyl] piperazine, structural formula such as formula one: [0003] [0004] formula one. [0005] There are two main synthetic routes of olaparib reported in the literature at present. [0006] In 2008, KuDOS Pharmaceuticals reported on J. Med. Chem. that the synthetic route of olaparib is as follows: [0007] [0008] This route adopts 2-fluoro-5-[(4-oxo-3,4-dihydronaphthalene-1-yl) methyl] benz...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D237/32
CPCC07D237/32
Inventor 杨鹏辉袁和亮刘武
Owner 南京亿华药业有限公司